Drug Trial Radar · NCT01255839
The Balloon Project for Birth Induction
Last checked: Nov 20, 2026Latest source record: Dec 8, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
825
Actual
Start
Dec 2002
Primary completion
Sep 2005
Study completion Dec 2010
Sponsor
- Lead sponsor
- Glostrup University Hospital, CopenhagenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 8, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Supportive care
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The use of prostaglandin E2 (PGE2) for induction of labour in women with unfavourable cervices is well-established1. There are, however, potential side effects to prostaglandins, in particular the risk of uterine hypertonicity which may affect fetal outcome. In theory a mechanical ripening based on dilatation of the cervix as well as induction of production of endogenous prostaglandin has potentially less influence on the fetal outcome but a Cochrane review from 2001 scrutinized studies on mechanical ripening versus placebo/no treatment or prostaglandin E2. They conclude there is insufficient data to evaluate the effectiveness in terms of likelihood of vaginal delivery in 24 hours, and emphasise the need for large sample size studies and substantive outcomes. Two later randomised studies compared mechanical ripening to PGE2 and found discrepant results regarding time from induction to delivery. The primary purpose of the present study was in a randomized design to compare the efficacy of double-balloon catheter versus vaginal PGE2 (minprostin 3 mg) on induction of labour, duration of birth and fetal outcome. Secondary analyses were to evaluate the results for various subgroups, i.e. primipara/multipara, gemelli, vaginal birth after caesarean, preterm birth and intra uterine growth restriction.
Conditions
- Induction Time
- Apgar Score
- Admission to Neonatal Unit
- Vaginal Delivery
- Caesarean Section
Interventions
Double BalloonDevice
The Double Balloon Catheter was applied (Atad 5) with 80 ml NaCl installed intrauterine above the intern orificium and 80 ml below in cervix/vagina.
MinprostinDrug
The prostaglandin 2 minprostin (3mg) was applied vaginally
Primary outcomes
What the sponsor says the trial is designed to measure.
- success of induction of labour, duration of birth and fetal outcomeTime frame: at birth
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Glostrup University Hospital
Glostrup Municipality, Glostrup, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.